Tango Therapeutics (TNGX) Receivables (2020 - 2022)

Tango Therapeutics' Receivables history runs 3 years deep, the most recent figure standing at $2.0 million for Q4 2022.

• In Q4 2022, Receivables changed 0.0% year-over-year to $2.0 million; the TTM figure through Dec 2022 stood at $2.0 million (changed 0.0% YoY), while the FY2022 annual figure was $2.0 million, changed 0.0% from the prior year.
• Receivables was $2.0 million for Q4 2022 at Tango Therapeutics, roughly flat from $2.0 million in the prior quarter.
• In the past five years, Receivables ranged from a high of $8.0 million in Q3 2021 to a low of $2.0 million in Q4 2020.
• Historically, Receivables has averaged $2.9 million across 3 years, with a median of $2.0 million in 2020.
• The sharpest annual moves came in 2021 and 2022: Receivables changed 0.0% in 2021, then sank 75.0% in 2022.
• A 3-year view of Receivables shows it stood at $2.0 million in 2020, then changed by 0.0% to $2.0 million in 2021, then changed by 0.0% to $2.0 million in 2022.
• The last three Receivables figures came in at $2.0 million (Q4 2022), $2.0 million (Q3 2022), and $2.0 million (Q2 2022), per Business Quant data.